COVID-19 Health Care Reform Prescription Drug Pricing 
Kaiser Health News
MARCH 15, 2023
“We had a massive opioid problem that needed to be rectified,” said Antonio Ciaccia, president of 3 Axis Advisors , a consulting firm that analyzes prescription drug pricing. in the past two decades, with a spike early in the covid-19 pandemic. The human toll of the opioid crisis is hard to overstate.
Health Populi
OCTOBER 24, 2022
These are shown in the first diagram from the report, breaking out factors that have exacerbated challenges on both the demand and supply side of the American health economy. Many of these were already in motion before the COVID-19 pandemic emerged; the public health crisis exacerbated several of them.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Kaiser Health News
MARCH 15, 2023
“We had a massive opioid problem that needed to be rectified,” said Antonio Ciaccia, president of 3 Axis Advisors , a consulting firm that analyzes prescription drug pricing. in the past two decades, with a spike early in the covid-19 pandemic. The human toll of the opioid crisis is hard to overstate.
Hall Render
MAY 10, 2024
Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass. Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’
Expert insights. Personalized for you.
97 
Let's personalize your content